GB8909022D0 - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
GB8909022D0
GB8909022D0 GB898909022A GB8909022A GB8909022D0 GB 8909022 D0 GB8909022 D0 GB 8909022D0 GB 898909022 A GB898909022 A GB 898909022A GB 8909022 A GB8909022 A GB 8909022A GB 8909022 D0 GB8909022 D0 GB 8909022D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB898909022A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cortecs Ltd
Original Assignee
Cortecs Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cortecs Ltd filed Critical Cortecs Ltd
Priority to GB898909022A priority Critical patent/GB8909022D0/en
Publication of GB8909022D0 publication Critical patent/GB8909022D0/en
Priority to PCT/GB1990/000605 priority patent/WO1990012583A1/fr
Priority to AU55412/90A priority patent/AU5541290A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/413—Gall bladder; Bile
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Biomedical Technology (AREA)
  • Botany (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GB898909022A 1989-04-20 1989-04-20 Pharmaceutical compositions Pending GB8909022D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GB898909022A GB8909022D0 (en) 1989-04-20 1989-04-20 Pharmaceutical compositions
PCT/GB1990/000605 WO1990012583A1 (fr) 1989-04-20 1990-04-20 Compositions pharmaceutiques
AU55412/90A AU5541290A (en) 1989-04-20 1990-04-20 Pharmaceutical compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898909022A GB8909022D0 (en) 1989-04-20 1989-04-20 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
GB8909022D0 true GB8909022D0 (en) 1989-06-07

Family

ID=10655408

Family Applications (1)

Application Number Title Priority Date Filing Date
GB898909022A Pending GB8909022D0 (en) 1989-04-20 1989-04-20 Pharmaceutical compositions

Country Status (3)

Country Link
AU (1) AU5541290A (fr)
GB (1) GB8909022D0 (fr)
WO (1) WO1990012583A1 (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9022788D0 (en) * 1990-10-19 1990-12-05 Cortecs Ltd Pharmaceutical formulations
GB9212511D0 (en) * 1992-06-12 1992-07-22 Cortecs Ltd Pharmaceutical compositions
US6551623B1 (en) 1993-09-09 2003-04-22 Lorus Therapeutics Inc. Immunomodulating compositions from bile
GB9325445D0 (en) * 1993-12-13 1994-02-16 Cortecs Ltd Pharmaceutical formulations
US5567592A (en) * 1994-02-02 1996-10-22 Regents Of The University Of California Screening method for the identification of bioenhancers through the inhibition of P-glycoprotein transport in the gut of a mammal
GB9417524D0 (en) * 1994-08-31 1994-10-19 Cortecs Ltd Pharmaceutical compositions
EP0814821A1 (fr) 1995-03-16 1998-01-07 Imutec Pharma Inc. Compositions immunomodulatrices d'origine biliaire destinees au traitement de troubles du systeme immunitaire
US5665386A (en) * 1995-06-07 1997-09-09 Avmax, Inc. Use of essential oils to increase bioavailability of oral pharmaceutical compounds
US5716928A (en) * 1995-06-07 1998-02-10 Avmax, Inc. Use of essential oils to increase bioavailability of oral pharmaceutical compounds
CA2224227A1 (fr) * 1995-06-07 1996-12-19 Avmax, Inc. Utilisation d'huiles essentielles pour accroitre la biodisponibilite des composes pharmaceutiques oraux
EP2422789B1 (fr) 2004-05-19 2017-11-22 Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center Composition injecable contenante de déoxycholate sodium
US7754230B2 (en) 2004-05-19 2010-07-13 The Regents Of The University Of California Methods and related compositions for reduction of fat
US20060127468A1 (en) 2004-05-19 2006-06-15 Kolodney Michael S Methods and related compositions for reduction of fat and skin tightening
US8101593B2 (en) 2009-03-03 2012-01-24 Kythera Biopharmaceuticals, Inc. Formulations of deoxycholic acid and salts thereof
MX363465B (es) 2011-02-18 2019-03-25 Kythera Biopharmaceuticals Inc Tratamiento de la grasa submental.
US8653058B2 (en) 2011-04-05 2014-02-18 Kythera Biopharmaceuticals, Inc. Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits
EP2645099A1 (fr) * 2012-03-30 2013-10-02 Phares Pharmaceutical Research N.V. Compositions biopertinentes
CA3137919A1 (fr) * 2019-05-20 2020-11-26 Poviva Corp. Compositions comprenant des agents biologiquement actifs et des sels biliaires

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7806048A (nl) * 1978-06-02 1979-12-04 Kali Chemie Pharma Gmbh Geneesmiddel met betere resorptie-eigenschappen en werkwijze voor de bereiding daarvan.
EP0179583A1 (fr) * 1984-10-04 1986-04-30 Merck & Co. Inc. Système pour augmenter la vitesse de dissolution dans l'eau et la solubilité de médicaments peu solubles

Also Published As

Publication number Publication date
AU5541290A (en) 1990-11-16
WO1990012583A1 (fr) 1990-11-01

Similar Documents

Publication Publication Date Title
ZA909426B (en) Pharmaceutical compositions
GB8921188D0 (en) Pharmaceutical compositions
CY1637A (en) Pharmaceutical compositions
GB8904182D0 (en) Pharmaceutical compositions
GB8909022D0 (en) Pharmaceutical compositions
ZA905511B (en) Pharmaceutical compositions
GB2232891B (en) Pharmaceutical composition
HUT56269A (en) Pharmaceutical compositions
GB9015436D0 (en) Pharmaceutical compositions
GB8909906D0 (en) Pharmaceutical compositions
GB8922130D0 (en) Pharmaceutical compositions
GB8922129D0 (en) Pharmaceutical compositions
GB8927109D0 (en) Pharmaceutical compositions
GB8922149D0 (en) Pharmaceutical compositions
GB8914099D0 (en) Pharmaceutical compositions
GB8902564D0 (en) Pharmaceutical compositions
IL89935A0 (en) Pharmaceutical compositions
GB8916070D0 (en) Pharmaceutical compositions
IE894216L (en) Pharmaceutical compositions
GB8909880D0 (en) Pharmaceutical compositions
GB8919447D0 (en) Pharmaceutical compositions
IE891521L (en) Pharmaceutical compositions
GB8919446D0 (en) Pharmaceutical compositions
IE892802L (en) Pharmaceutical compositions
IE892803L (en) Pharmaceutical compositions